Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells

被引:0
|
作者
Oshimi, Y
Oda, S
Honda, Y
Nagata, S
Miyazaki, S
机构
[1] TOKYO WOMENS MED COLL, DEPT PHYSIOL, SHINJUKU KU, TOKYO 162, JAPAN
[2] OSAKA UNIV, SCH MED, DEPT GENET, SUITA, OSAKA 565, JAPAN
[3] OSAKA BIOSCI INST, SUITA, OSAKA 565, JAPAN
[4] NATL INST PHYSIOL SCI, DEPT MOL PHYSIOL, LAB INTRACELLULAR METAB, OKAZAKI, AICHI 444, JAPAN
来源
JOURNAL OF IMMUNOLOGY | 1996年 / 157卷 / 07期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The cytotoxicity of NK cells has been thought to be mediated mainly by the perforin-dependent pathway. We investigated the involvement of Fas-mediated pathway in the killing activity of purified human CD3(-), CD16(+) NK cells. Fas ligand mRNA was expressed in freshly isolated NK cells. Apoptosis, which was identified by the fragmented chromatin in individual cells, was induced in the cells that expressed high levels of Fas via direct NK-to-target cell interaction or Ab-dependent cell-mediated cytotoxicity, even in Ca2+-free medium, in which perforin pores are known not to be formed. Apoptosis in both the presence and absence of external Ca2+ was inhibited by Fab of an anti-fas mAb. Transfection of the Fas gene in target cells facilitated the induction of apoptosis, compared with the parental cell line. The function of the Fas-mediated pathway in the coexistence of the perforin-dependent pathway was examined in 10 cell lines expressing different levels of Fas by Ca2+ imaging and morphologic observation of single cells. With a certain boundary level, low or high levels of Fas expression in target cells were correlated to a great degree with either acute necrosis due to severe membrane damage after NK-target cell contact or apoptosis at a later period, respectively. We concluded that Fas ligand/Fas interaction is present and plays a significant role in the human NK cell-induced apoptosis.
引用
收藏
页码:2909 / 2915
页数:7
相关论文
共 50 条
  • [1] FAS-MEDIATED CYTOTOXICITY BY FRESHLY ISOLATED NATURAL-KILLER-CELLS
    ARASE, H
    ARASE, N
    SAITO, T
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03): : 1235 - 1238
  • [2] Inhibition of Fas-mediated cytotoxicity by HLA Class I in natural killer cells
    Lin, H
    Chua, Z
    FASEB JOURNAL, 2001, 15 (05): : A1036 - A1036
  • [3] FAS INVOLVEMENT IN CYTOTOXICITY MEDIATED BY HUMAN NK CELLS
    MONTEL, AH
    BOCHAN, MR
    HOBBS, JA
    LYNCH, DH
    BRAHMI, Z
    CELLULAR IMMUNOLOGY, 1995, 166 (02) : 236 - 246
  • [4] The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent
    Shunsuke Mori
    Anahid Jewett
    Kaoru Murakami-Mori
    Marta Cavalcanti
    B. Bonavida
    Cancer Immunology, Immunotherapy, 1997, 44 : 282 - 290
  • [5] The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent
    Mori, S
    Jewett, A
    MurakamiMori, K
    Cavalcanti, M
    Bonavida, B
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1997, 44 (05) : 282 - 290
  • [6] Involvement of the Fas ligand and Fas system in apoptosis induction of mouse uterine natural killer cells
    Kusakabe, K
    Otsuki, Y
    Kiso, Y
    JOURNAL OF REPRODUCTION AND DEVELOPMENT, 2005, 51 (03): : 333 - 340
  • [7] Fas expression on human fetal astrocytes without susceptibility to fas-mediated cytotoxicity
    Becher, B
    D'Souza, SD
    Troutt, AB
    Antel, JP
    NEUROSCIENCE, 1998, 84 (02) : 627 - 634
  • [8] Doxorubicin sensitizes human bladder carcinoma cells to Fas-mediated cytotoxicity
    Mizutani, Y
    Okada, Y
    Yoshida, O
    Fukumoto, M
    Bonavida, B
    CANCER, 1997, 79 (06) : 1180 - 1189
  • [9] Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis
    Ungefroren, H
    Voss, M
    Jansen, M
    Roeder, C
    Henne-Bruns, D
    Kremer, B
    Kalthoff, H
    CANCER RESEARCH, 1998, 58 (08) : 1741 - 1749
  • [10] Mitochondrial involvement in Fas-mediated apoptosis of human lumbar disc cells
    Park, JB
    Li, JK
    Park, SJ
    Kim, KW
    Riew, KD
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2005, 87A (06): : 1338 - 1342